Perioperative Toripalimab Plus Chemotherapy for the Treatment of Patients With Resectable NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial
JAMA 2024 Jan 16;331(3)201-211, S Lu, W Zhang, L Wu, W Wang, P Zhang, , W Fang, W Xing, Q Chen, L Yang, J Mei, L Tan, X Sun, S Xu, X Hu, G Yu, D Yu, N Yang, Y Chen, J Shan, L Xing, H Tian, X Zhang, M Zhou, H Fang, G Wu, Y Liu, M Ye, L Cao, J Jiang, X Li, L Zhu, D Li, M Kang, A Zhong, K Chen, N Wu, Q Sun, H Ma, K Cai, C Wang, G Lin, K Zhu, Y Zhang, X Zhang, H Hu, W Zhang, J Chen, Z Yang, X Hang, J Hu, Y Huang, Z Zhang, L Zhang, L Zhang, L Liu, D Lin, J Zhang, G Chen, Y Li, L Zhu, W Wang, W Yu, D Cao, P Keegan, S YaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.